Schrodinger SDGR Peer Comparison

NASDAQ SDGR
$20.09 -0.62 (-2.99%)
At close: Sep 4, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Healthcare IT

Schrodinger, Inc. (SDGR) is the 180th largest of 300 Healthcare IT companies by market capitalisation, at 1.32 Bn, behind Afya Ltd at 1.33 Bn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 VEEV Veeva Systems Inc primary T-27 Vertical Software TG-05 44.53 Bn 0.00 Mn 12.88 37.29 Bn
2 WAY Waystar Holding Corp. primary T-27 Vertical Software TG-05 4.81 Bn 0.00 Mn 3.99 4.62 Bn
3 DOCS Doximity, Inc. primary T-27 Vertical Software TG-05 4.74 Bn 0.00 Mn 7.23 4.05 Bn
4 CCC CCC Intelligent Solutions Holdings Inc. primary T-27 Vertical Software TG-05 4.41 Bn 0.00 Mn 3.97 4.30 Bn
5 EVCM EverCommerce Inc. primary T-27 Vertical Software TG-05 1.40 Bn 0.00 Mn 2.34 1.27 Bn
6 SDGR Schrodinger, Inc. primary T-27 Vertical Software TG-05 1.32 Bn 0.00 Mn 5.09 0.90 Bn
7 CERT Certara, Inc. primary T-27 Vertical Software TG-05 1.21 Bn 0.00 Mn 2.96 1.03 Bn
8 GDRX GoodRx Holdings, Inc. primary T-27 Vertical Software TG-05 1.18 Bn 0.00 Mn 1.51 0.89 Bn
9 HSTM Healthstream Inc primary T-27 Vertical Software TG-05 0.85 Bn 0.00 Mn 2.66 0.79 Bn
10 PHR Phreesia, Inc. primary T-27 Vertical Software TG-05 0.68 Bn 0.00 Mn 1.33 0.68 Bn
11 CTEV Claritev Corp primary T-27 Vertical Software TG-05 0.65 Bn 0.00 Mn 0.65 0.63 Bn
12 WEAV Weave Communications, Inc. primary T-27 Vertical Software TG-05 0.58 Bn 0.00 Mn 2.27 0.54 Bn
13 SOPH SOPHiA GENETICS SA primary T-27 Vertical Software TG-05 0.55 Bn 0.00 Mn 6.43 0.45 Bn
14 NRC Nrc Health primary T-27 Vertical Software TG-05 0.48 Bn 0.00 Mn 3.40 0.47 Bn
15 SLP Simulations Plus, Inc. primary T-27 Vertical Software TG-05 0.37 Bn 0.00 Mn 4.54 0.32 Bn
16 SPOK Spok Holdings, Inc primary T-27 Vertical Software TG-05 0.22 Bn 0.00 Mn 1.65 0.21 Bn
17 AMWL American Well Corp primary T-27 Vertical Software TG-05 0.22 Bn 0.00 Mn 1.00 0.04 Bn
18 BRRN Bryn Inc. primary T-27 Vertical Software TG-05 0.16 Bn 0.00 Mn — 0.16 Bn
19 OPRX OptimizeRx Corp primary T-27 Vertical Software TG-05 0.15 Bn 0.00 Mn 1.50 0.12 Bn
20 HCAT Health Catalyst, Inc. primary T-27 Vertical Software TG-05 0.13 Bn 0.00 Mn 0.43 0.02 Bn
21 DH Definitive Healthcare Corp. primary T-27 Vertical Software TG-05 0.11 Bn 0.00 Mn 0.48 -0.03 Bn
22 CCLD CareCloud, Inc. primary T-27 Vertical Software TG-05 0.09 Bn 0.00 Mn 0.74 0.08 Bn
23 RSSS Research Solutions, Inc. primary T-27 Vertical Software TG-05 0.07 Bn 0.00 Mn 1.52 0.06 Bn
24 DRIO DarioHealth Corp. primary T-27 Vertical Software TG-05 0.07 Bn 0.00 Mn 3.22 0.05 Bn
25 ONMD OneMedNet Corp primary T-27 Vertical Software TG-05 0.04 Bn 0.00 Mn 26.96 0.04 Bn
26 VYND Vynleads, Inc. primary T-27 Vertical Software TG-05 0.01 Bn 0.00 Mn — 0.01 Bn
27 HLYK HealthLynked Corp primary T-27 Vertical Software TG-05 0.01 Bn 0.00 Mn 5.45 0.01 Bn
28 ACON Aclarion, Inc. primary T-27 Vertical Software TG-05 0.01 Bn 0.00 Mn 69.07 0.01 Bn
29 AMST Amesite Inc. primary T-27 Vertical Software TG-05 0.01 Bn 0.00 Mn 14.85 0.01 Bn
30 DOGP Dogecoin Cash, Inc. primary T-27 Vertical Software TG-05 0.00 Bn 0.00 Mn 2.26 0.00 Bn
31 VSEE Vsee Health, Inc. primary T-27 Vertical Software TG-05 0.00 Bn 0.00 Mn 0.09 0.00 Bn
32 WORXD SCWorx Corp. primary T-27 Vertical Software TG-05 0.00 Bn 0.00 Mn 0.15 0.00 Bn
33 SOBR SOBR Safe, Inc. primary T-27 Vertical Software TG-05 0.00 Bn 0.00 Mn 1.05 0.00 Bn
34 ZCMD Zhongchao Inc. primary T-27 Vertical Software TG-05 0.00 Bn 0.00 Mn 0.00 -0.01 Bn
35 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 0.00 Mn 6.77 642.33 Bn
36 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 0.00 Mn 7.04 446.51 Bn
37 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 0.00 Mn 5.57 363.78 Bn
38 UNH Unitedhealth Group Inc secondary H-18 Healthcare Payers and Distributors HG-05 359.38 Bn 0.00 Mn 0.80 333.97 Bn
39 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 0.00 Mn 6.20 222.38 Bn
40 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn 0.00 Mn 6.15 184.12 Bn
41 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 0.00 Mn 10.99 130.51 Bn
42 MCK Mckesson Corp secondary H-19 Healthcare Payers and Distributors HG-05 105.79 Bn 0.00 Mn 0.26 103.19 Bn
43 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 0.00 Mn 5.48 77.10 Bn
44 RELX Relx Plc secondary T-23 Business Applications TG-03 64.63 Bn 0.00 Mn 4.50 64.32 Bn
45 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 0.00 Mn 12.23 58.75 Bn
46 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn 0.00 Mn 26.07 52.94 Bn
47 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 0.00 Mn 1.01 46.98 Bn
48 NTRA Natera, Inc. secondary H-17 Healthcare Providers HG-04 47.13 Bn 0.00 Mn 17.41 46.03 Bn
49 IQV Iqvia Holdings Inc. secondary H-11 Pharma Services HG-03 44.06 Bn 0.00 Mn 2.59 42.11 Bn
50 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 0.00 Mn 2.45 38.68 Bn
51 ONC BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 40.49 Bn 0.00 Mn 6.61 35.39 Bn
52 ROP Roper Technologies Inc secondary T-19 Business Applications TG-03 40.28 Bn 0.00 Mn 4.86 39.92 Bn
53 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 0.00 Mn 7.41 32.28 Bn
54 RMD Resmed Inc secondary H-06 Medical Devices and Diagnostics HG-02 32.94 Bn 0.00 Mn 5.83 31.47 Bn
55 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 0.00 Mn 3.25 31.34 Bn
56 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.10 Bn 0.00 Mn 1.46 29.22 Bn
57 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn 0.00 Mn 24.23 26.41 Bn
58 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn 0.00 Mn 8.48 12.58 Bn
59 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 0.00 Mn 4.38 20.94 Bn
60 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn 0.00 Mn 2,310.98 25.93 Bn
61 GPN Global Payments Inc secondary T-54 Fintech TG-09 24.60 Bn 0.00 Mn 2.40 19.84 Bn
62 SSNC SS&C Technologies Holdings Inc secondary T-20 Business Applications TG-03 19.62 Bn 0.00 Mn 2.99 19.26 Bn
63 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.70 Bn 0.00 Mn 2.20 18.30 Bn
64 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 0.00 Mn 13.73 15.82 Bn
65 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 0.00 Mn 3.48 14.40 Bn
66 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 0.00 Mn 4.69 15.42 Bn
67 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn 0.00 Mn 12.28 14.93 Bn
68 SOLV Solventum Corp secondary H-06 Medical Devices and Diagnostics HG-02 15.60 Bn 0.00 Mn 1.88 15.19 Bn
69 TU Telus Corp secondary C-01 Telecommunications CG-01 14.98 Bn 0.00 Mn 0.68 14.45 Bn
70 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 0.00 Mn 6.03 13.85 Bn
71 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 0.00 Mn 20.50 13.91 Bn
72 RVTY Revvity, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 14.53 Bn 0.00 Mn 4.99 13.51 Bn
73 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
74 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 0.00 Mn 3.78 12.00 Bn
75 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 0.00 Mn 7.55 12.34 Bn
76 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn 0.00 Mn 18.20 10.58 Bn
77 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 0.00 Mn 14.45 11.63 Bn
78 DVA Davita Inc. secondary H-14 Healthcare Providers HG-04 11.76 Bn 0.00 Mn 0.84 12.64 Bn
79 TEM Tempus AI, Inc. secondary H-17 Healthcare Providers HG-04 11.32 Bn 0.00 Mn 7.91 10.51 Bn
80 ALGN Align Technology Inc secondary H-09 Medical Devices and Diagnostics HG-02 11.30 Bn 0.00 Mn 2.73 10.20 Bn
81 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn 0.00 Mn 13.92 10.49 Bn
82 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.51 Bn 0.00 Mn 3.34 9.91 Bn
83 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
84 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn 0.00 Mn — 10.11 Bn
85 HSIC Henry Schein Inc secondary H-19 Healthcare Payers and Distributors HG-05 10.05 Bn 0.00 Mn 0.74 10.80 Bn
86 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 0.00 Mn 2.73 9.85 Bn
87 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn 0.00 Mn — 9.06 Bn
88 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn 0.00 Mn 11.01 7.57 Bn
89 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 0.00 Mn 33.42 9.42 Bn
90 ABVX Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.02 Bn 0.00 Mn — 9.02 Bn
91 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn 0.00 Mn — 8.86 Bn
92 OSCR Oscar Health, Inc. secondary H-18 Healthcare Payers and Distributors HG-05 8.81 Bn 0.00 Mn 0.58 0.26 Bn
93 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 0.00 Mn 10.72 7.89 Bn
94 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn 0.00 Mn 51.33 8.15 Bn
95 TXG 10x Genomics, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 8.16 Bn 0.00 Mn 13.23 7.61 Bn
96 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn 0.00 Mn — 8.10 Bn
97 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn 0.00 Mn — 7.84 Bn
98 HNGE Hinge Health, Inc. secondary H-16 Healthcare Providers HG-04 7.41 Bn 0.00 Mn 10.30 7.03 Bn
99 CAI Caris Life Sciences, Inc. secondary H-17 Healthcare Providers HG-04 7.08 Bn 0.00 Mn 7.16 6.29 Bn
100 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn 0.00 Mn 29.47 6.74 Bn
101 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn 0.00 Mn 5,007.81 6.97 Bn
102 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn 0.00 Mn — 6.73 Bn
103 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn 0.00 Mn 1,058.74 6.59 Bn
104 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn 0.00 Mn 10.57 6.10 Bn
105 NICE NICE Ltd. secondary T-26 Workplace Software TG-04 6.38 Bn 0.00 Mn 1.08 6.02 Bn
106 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn 0.00 Mn — 5.96 Bn
107 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn 0.00 Mn 1,163.52 5.66 Bn
108 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
109 RDNT RadNet, Inc. secondary H-14 Healthcare Providers HG-04 5.80 Bn 0.00 Mn 2.55 5.37 Bn
110 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 0.00 Mn — 5.78 Bn
111 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 0.00 Mn 5.72 3.55 Bn
112 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 0.00 Mn 19.58 4.33 Bn
113 EXLS ExlService Holdings, Inc. secondary T-63 Technology Services TG-11 5.56 Bn 0.00 Mn 2.48 5.27 Bn
114 GRFS Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.31 Bn 0.00 Mn 0.32 6.86 Bn
115 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn 0.00 Mn — 5.06 Bn
116 RADX Radiopharm Theranostics Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.92 Bn 0.00 Mn 20,296.96 4.92 Bn
117 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn 0.00 Mn — 4.68 Bn
118 HAE Haemonetics Corp secondary H-06 Medical Devices and Diagnostics HG-02 4.68 Bn 0.00 Mn 3.46 4.46 Bn
119 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
120 HTFL Heartflow, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 4.24 Bn 0.00 Mn 20.90 3.87 Bn
121 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn 0.00 Mn 402.01 4.16 Bn
122 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn 0.00 Mn — 4.07 Bn
123 TLX Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.04 Bn — — 3.75 Bn
124 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn 0.00 Mn — 4.02 Bn
125 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn 0.00 Mn 12.25 3.68 Bn
126 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn 0.00 Mn 16.41 3.01 Bn
127 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn 0.00 Mn — 3.80 Bn
128 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn 0.00 Mn 70.47 2.78 Bn
129 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn 0.00 Mn 32.18 3.06 Bn
130 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn 0.00 Mn 987.61 3.56 Bn
131 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn 0.00 Mn 52.94 3.50 Bn
132 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 0.00 Mn 19,714.47 3.11 Bn
133 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn 0.00 Mn — 3.04 Bn
134 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn 0.00 Mn 593.06 2.51 Bn
135 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 0.00 Mn 6.47 2.76 Bn
136 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn 0.00 Mn — 2.96 Bn
137 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn 0.00 Mn 6.55 2.24 Bn
138 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn 0.00 Mn — 2.80 Bn
139 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn 0.00 Mn 553.22 2.73 Bn
140 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn 0.00 Mn 73.73 2.27 Bn
141 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 0.00 Mn 0.06 -3.12 Bn
142 CDNA CareDx, Inc. secondary H-17 Healthcare Providers HG-04 2.62 Bn 0.00 Mn 5.72 2.25 Bn
143 PRVA Privia Health Group, Inc. secondary H-14 Healthcare Providers HG-04 2.61 Bn 0.00 Mn 1.11 2.25 Bn
144 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn 0.00 Mn 36.49 2.60 Bn
145 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.59 Bn 0.00 Mn 10.31 2.48 Bn
146 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn 0.00 Mn — 2.59 Bn
147 WGS GeneDx Holdings Corp. secondary H-17 Healthcare Providers HG-04 2.56 Bn 0.00 Mn 5.64 2.43 Bn
148 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn 0.00 Mn 4.75 2.19 Bn
149 LIFE Ethos Technologies Inc. secondary H-16 Healthcare Providers HG-04 2.54 Bn 0.00 Mn 4.49 2.37 Bn
150 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn 0.00 Mn 3.21 2.16 Bn
151 HURN Huron Consulting Group Inc. secondary I-26 Business Services IG-06 2.47 Bn 0.00 Mn 1.76 2.44 Bn
152 HCM HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 0.00 Mn 3.41 2.47 Bn
153 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 0.00 Mn 2.56 1.65 Bn
154 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 44.92 1.77 Bn
155 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn 0.00 Mn — 2.38 Bn
156 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.38 Bn 0.00 Mn 1.20 1.58 Bn
157 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 0.00 Mn — 2.10 Bn
158 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn 0.00 Mn 13.89 2.36 Bn
159 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn 0.00 Mn 44.88 2.34 Bn
160 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn 0.00 Mn — 1.93 Bn
161 FLYW Flywire Corp secondary T-54 Fintech TG-09 2.26 Bn 0.00 Mn 3.16 1.96 Bn
162 CLOV Clover Health Investments, Corp. /De secondary H-18 Healthcare Payers and Distributors HG-05 2.25 Bn 0.00 Mn 0.91 2.02 Bn
163 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn 0.00 Mn — 2.22 Bn
164 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 109.75 2.19 Bn
165 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 4.23 2.03 Bn
166 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 0.34 0.66 Bn
167 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 11.42 2.05 Bn
168 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.00 Mn 6.86 1.69 Bn
169 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 56.15 1.81 Bn
170 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 2,082.32 2.08 Bn
171 PGNY Progyny, Inc. secondary H-14 Healthcare Providers HG-04 2.01 Bn 0.00 Mn 1.53 1.77 Bn
172 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn 0.00 Mn 18.84 1.60 Bn
173 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.06 1.97 Bn
174 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn 0.00 Mn 35.35 1.39 Bn
175 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn 0.00 Mn 6.35 1.93 Bn
176 INOD Innodata Inc secondary T-63 Technology Services TG-11 1.91 Bn 0.00 Mn 6.03 1.66 Bn
177 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
178 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn 67.43 1.57 Bn
179 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn 4.32 0.98 Bn
180 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn — 1.32 Bn
181 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn 7.27 1.29 Bn
182 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn 0.00 Mn — 1.80 Bn
183 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn 0.00 Mn 1,370.98 1.78 Bn
184 BFLY Butterfly Network, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 1.75 Bn 0.00 Mn 15.62 1.62 Bn
185 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn 0.00 Mn — 1.39 Bn
186 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn 0.00 Mn 1,008.79 1.73 Bn
187 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn 0.00 Mn — 1.71 Bn
188 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 4.07 0.97 Bn
189 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 16.97 1.68 Bn
190 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn 20.12 1.38 Bn
191 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 0.00 Mn 8.28 1.36 Bn
192 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
193 OMCL Omnicell, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 1.57 Bn 0.00 Mn 1.26 1.28 Bn
194 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn 0.00 Mn — 1.53 Bn
195 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 0.00 Mn 969.66 1.31 Bn
196 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 0.00 Mn 2.10 1.22 Bn
197 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 0.00 Mn — 1.50 Bn
198 KMTS Kestra Medical Technologies, Ltd. secondary H-06 Medical Devices and Diagnostics HG-02 1.49 Bn 0.00 Mn 15.68 1.13 Bn
199 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn 0.00 Mn 72.74 1.45 Bn
200 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn 0.00 Mn — 1.42 Bn
201 TNDM Tandem Diabetes Care Inc secondary H-06 Medical Devices and Diagnostics HG-02 1.38 Bn 0.00 Mn 1.33 0.93 Bn
202 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 165.97 0.88 Bn
203 AZTA Azenta, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 1.37 Bn 0.00 Mn 1.30 1.05 Bn
204 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn 35.55 1.37 Bn
205 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
206 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn 0.00 Mn — 1.33 Bn
207 CLVT Clarivate Plc secondary T-22 Business Applications TG-03 1.33 Bn 0.00 Mn 0.55 1.11 Bn
208 AFYA Afya Ltd secondary D-28 Consumer Services DG-09 1.33 Bn 0.00 Mn 1.25 1.14 Bn
209 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.28 Bn 0.00 Mn 26.37 0.82 Bn
210 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn 0.00 Mn — 0.74 Bn
211 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn — 1.26 Bn
212 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn — 1.26 Bn
213 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 3.20 1.15 Bn
214 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn 0.00 Mn — 1.25 Bn
215 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn 0.00 Mn 51.51 1.24 Bn
216 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn 0.00 Mn — 1.00 Bn
217 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn — 1.18 Bn
218 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn 41.06 0.55 Bn
219 TDOC Teladoc Health, Inc. secondary H-16 Healthcare Providers HG-04 1.14 Bn 0.00 Mn 0.46 0.37 Bn
220 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn 0.00 Mn — 1.10 Bn
221 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn 0.00 Mn — 1.06 Bn
222 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 0.00 Mn 5.60 0.93 Bn
223 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 4.14 0.71 Bn
224 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn 0.00 Mn — 0.95 Bn
225 CBLL Ceribell, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 0.94 Bn 0.00 Mn 9.27 0.82 Bn
226 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn 0.00 Mn 2.09 0.66 Bn
227 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn 0.00 Mn 14.37 0.57 Bn
228 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 0.00 Mn 3.28 0.81 Bn
229 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 0.00 Mn 8.50 0.50 Bn
230 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 881.20 0.88 Bn
231 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn 0.00 Mn 104.97 0.86 Bn
232 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn 0.00 Mn — 0.85 Bn
233 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
234 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn 0.00 Mn 44.17 0.48 Bn
235 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn — 0.79 Bn
236 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 2.37 0.63 Bn
237 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 0.00 Mn — 0.71 Bn
238 PAYS Paysign, Inc. secondary T-54 Fintech TG-09 0.76 Bn 0.00 Mn 7.55 0.58 Bn
239 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 0.00 Mn 8.48 0.61 Bn
240 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 0.00 Mn 5.40 0.51 Bn
241 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 0.00 Mn 9.71 0.41 Bn
242 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.49 Bn
243 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.81 0.62 Bn
244 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,120.86 0.62 Bn
245 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 0.00 Mn — 0.67 Bn
246 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 0.00 Mn 1.75 0.40 Bn
247 CCSI Consensus Cloud Solutions, Inc. secondary T-26 Workplace Software TG-04 0.65 Bn 0.00 Mn 1.83 0.55 Bn
248 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -0.36 Mn — 0.64 Bn
249 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn 16.37 0.58 Bn
250 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn — 0.63 Bn
251 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.94 0.05 Bn
252 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn 551.86 Mn 3.59 0.46 Bn
253 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 0.00 Mn — 0.59 Bn
254 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn — 0.58 Bn
255 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn 557.79 0.41 Bn
256 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 0.00 Mn — 0.56 Bn
257 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.54 Bn 0.00 Mn 2.25 0.28 Bn
258 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn 0.00 Mn 326.79 0.40 Bn
259 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn 0.00 Mn 78.36 0.28 Bn
260 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn 0.00 Mn 9.32 0.22 Bn
261 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn — 0.50 Bn
262 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.49 Bn 0.00 Mn 330.55 0.49 Bn
263 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.57 0.42 Bn
264 EVH Evolent Health, Inc. secondary H-14 Healthcare Providers HG-04 0.49 Bn 0.00 Mn 0.23 0.35 Bn
265 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.11 0.39 Bn
266 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
267 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
268 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
269 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn 13.19 0.21 Bn
270 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn 100.68 0.36 Bn
271 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.31 0.26 Bn
272 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 0.00 Mn — 0.45 Bn
273 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 44.52 0.24 Bn
274 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn — 0.44 Bn
275 MTLS Materialise Nv secondary T-20 Business Applications TG-03 0.44 Bn 0.00 Mn 1.38 0.44 Bn
276 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 42.40 0.44 Bn
277 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 19.43 0.16 Bn
278 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn — 0.43 Bn
279 HBB Hamilton Beach Brands Holding Co secondary D-06 Household Durables DG-02 0.42 Bn 0.00 Mn 0.68 0.32 Bn
280 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.28 0.22 Bn
281 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
282 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn 0.00 Mn 139.55 0.21 Bn
283 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
284 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.38 Bn 0.00 Mn 0.45 0.27 Bn
285 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn 0.00 Mn — 0.36 Bn
286 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 0.00 Mn 2.65 0.34 Bn
287 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
288 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.33 Bn
289 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.70 0.17 Bn
290 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 104.23 0.33 Bn
291 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 5.52 0.16 Bn
292 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn 0.00 Mn — 0.31 Bn
293 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.31 Bn 0.00 Mn 6.82 0.26 Bn
294 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn 0.00 Mn — 0.31 Bn
295 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.90 0.30 Bn
296 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.19 Bn
297 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 13.14 0.29 Bn
298 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 7.86 0.22 Bn
299 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 0.01 -10.78 Bn
300 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 1.67 0.17 Bn